Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miguel Maldonado-Avila is active.

Publication


Featured researches published by Miguel Maldonado-Avila.


Urology | 2014

Emphysematous Pyelonephritis: Multicenter Clinical and Therapeutic Experience in Mexico

Daniel Olvera-Posada; Ghislaine Armengod-Fischer; Luis Gabriel Vázquez-Lavista; Miguel Maldonado-Avila; Emmanuel Rosas-Nava; Ha Manzanilla-García; Ricardo Castillejos-Molina; Carlos E. Méndez-Probst; Mariano Sotomayor; Guillermo Feria-Bernal; Francisco Rodríguez-Covarrubias

OBJECTIVE To analyze the outcomes of emphysematous pyelonephritis (EPN), the impact of different treatment modalities, and to determine risk factors associated with mortality. METHODS We retrospectively reviewed cases of EPN from 3 tertiary care institutions in Mexico. The diagnosis was confirmed with computed tomographic scan. Treatment was classified as follows: medical management (MM), minimally invasive, and surgical. Demographic, clinical, biochemical, and radiological characteristics were assessed and compared between survivors and nonsurvivors. Comparison was assessed using 1-way analysis of variance and chi-square. Univariate and multivariate logistic regression analyses were performed to determine prognostic factors. Main end point was mortality. RESULTS A total of 62 patients were included (49 women and 13 men), with a mean age of 53.9 years. The most common comorbidities were diabetes (69.3%) and hypertension (40.3%). Escherichia coli was the most common isolated microorganism (62.7%). MM was provided to 24.2%, minimally invasive treatment to 51.6%, open drainage to 19.3%, and emergency nephrectomy to 4.8%. Overall mortality was 14.5% and was similar among different treatment modalities (P=.06). Survivors were younger (P=.004), had lower creatinine (P=.002), and better estimated glomerular filtration rate (P=.007). In univariate analysis, age (P=.009), creatinine (P=.009), and need for nephrectomy (P=.03) were associated with mortality. In multivariate logistic regression analysis, creatinine (odds ratio 1.56, 95% confidence interval 1.03-2.35, P=.03) and nephrectomy (odds ratio 9.7, 95% confidence interval 1.007-93.51, P=.049) remained significant predictors of mortality. CONCLUSION EPN needs an aggressive MM and stepwise approach; nephrectomy should be the last resort of treatment. Creatinine level and need for nephrectomy are the strongest predictors of mortality according our analysis.


International Braz J Urol | 2016

Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms

Miguel Maldonado-Avila; Leopoldo Mateo Garduño-Arteaga; Rene Jungfermann-Guzman; Ha Manzanilla-García; Emmanuel Rosas-Nava; Nestor Procuna-Hernandez; Alejandro Vela-Mollinedo; Luis Almazan-Treviño; José Guzmán-Esquivel

ABSTRACT Introduction and objective Indwelling double J ureteral stents are used routinely in the resolution of ureteral obstruction caused by different etiologies. Evaluation of urinary symptoms related to double-J stent, indicate that these affect 73-90% of patients. We conducted a prospective, randomized study, to evaluate the efficacy of tamsulosin, oxybutinin and combination therapy in improving the urinary symptoms. Methods Patients who underwent ureteral stent placement after ureterolithotripsy (total 51), were randomized into three groups: Group I: Tamsulosin 0.4 mg. once per day(17 patients), Group II: Oxybutinin 5 mg. once per day (17 patients), Group III: Tamsulosin+ oxybutynin once per day (17 patients). All the groups received the drugs for three weeks and completed a Spanish validated Ureteral Stent Symptom Questionnaire (USSQ) at day 7 and 21. Results Repeated measures ANOVA showed mean urinary symptom index score was 22.3 vs. 15.5 in group three (p<0.001) at day 7 and 21 respectively. The mean work performance index was 6.6 vs 8.1 (p=0.049) favoring tamsulosin group, the mean sexual score was 0.5 vs 1.5 (p=0.03). Among additional problems the mean was 7.2 vs 6.2 (p=0.03). No significant difference was noted among pain and general health index. No side effects were reported. Conclusions Combination therapy with tamsulosin and oxybutynin improved irritative symptoms and work performance as well as sexual matters. Combination therapy should be considered for patients who complained of stent related symptoms.


AME Medical Journal | 2018

Enucleation of schwannoma of the penis with neurovascular bundle sparing using the VTI 20 MHz Microvascular Doppler System

Miguel Maldonado-Avila; Flor Maria Cano-Escobar; Guillermo Soria-Fernández; Isaac Roberto Labra-Salgado; Christian Acevedo-García; Je Rosas-Nava; Maria Martha Castro-Ibarra; Jesus Rosendo Soto-Perez; Hugo Rivera-Astorga; Maria Luisa Paulette Avila-Boza; Daniel Calvo-Mena; Saulo Mendoza-Ramirez; Janeet Garduño-Becerra

A 48-year-old man had an unremarkable past medical history. His current illness began 8 years prior to medical consultation with a non-painful, progressive increase in volume at the base of the penis in the dorsal region. The patient had adequate erections but was unable to perform coitus due to the presence of a mass. He complained of no other symptomatology. Physical examination revealed an uncircumcised cylindrical penis and a central meatus. A non-painful, mobile, stony hard tumor measuring approximately 6 cm × 5 cm was located at the dorsal region of the base of the penis. It was not fixed to the deep planes and there were no color changes. MRI of the penis identified a round, solid, well-circumscribed tumor with a heterogeneous content and extremely vascularized aspect. It was not dependent on the corpora cavernosa but caused compression and displacement to the left. The penile tumor was completely extirpated using the VTI 20 MHz Microvascular Doppler System, sparing the neurovascular bundles. The histopathologic report and immunohistochemistry study confirmed the diagnosis of Schwannoma of the penis. At follow-up at more than two years, the patient has no signs of tumor activity and erections are adequate.


Revista Mexicana de Urología | 2014

Estudio comparativo en el manejo laparoscópico transperitoneal y lumboscópico de quistes renales

J.E. Rosas-Nava; L. Almazan-Treviño; D. Ramírez-Limón; V.E. Corona-Montes; Mario S Almanza-González; Miguel Maldonado-Avila; Ha Manzanilla-García

Resumen Introduccion Los quistes renales sintomaticos requieren manejo quirurgico. Objetivo Comparar los resultados en el manejo de quistes renales mediante abordaje laparoscopico transperitoneal y lumboscopico. Material y metodo Estudio prospectivo, descriptivo, longitudinal, en pacientes con diagnostico de quiste renal Bosniak I sintomatico. Se dividen en 2 grupos: grupo 1, laparoscopia transperitoneal y grupo 2, lumboscopia. Variables: sangrado transoperatorio, dias de estancia hospitalaria y edad. Resultados Veintiocho pacientes, grupo 1: 19 pacientes, y grupo 2: 9 pacientes. Grupo 1, medias: edad 52 anos, tamano del quiste 6.6 cm, dias de estancia 1.26, sangrado transoperatorio 20.5 mL. Grupo 2, medias: edad 63 anos, tamano del quiste 7.3 cm, dias de estancia 1.11, sangrado transoperatorio 20 mL. Se encontro diferencia estadisticamente significativa en la edad (p=0.01), no asi en el tamano del quiste (p=0.3), dias de estancia (p=0.3) y sangrado transoperatorio (p=0.9). No hubo complicaciones. Discusion Se han publicado buenos resultados con el manejo laparoscopico de los quistes renales, sin embargo son series pequenas y con poco seguimiento. En la literatura se reportan promedios de sangrado transoperatorio de 70-150 cc, siendo menor en nuestro estudio (20 cc); asi como promedios de 3 dias de estancia, encontrandonos por debajo (1.2 dias). Conclusion Nuestro estudio nos aclara y aporta que no existen diferencias estadisticamente significativas entre ambos abordajes; este dependera de la localizacion del quiste, asi como la preferencia y experiencia del cirujano.


International Urology and Nephrology | 2014

A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth

Miguel Maldonado-Avila; Ha Manzanilla-García; José Alfredo Sierra-Ramírez; José Damián Carrillo-Ruiz; Juan Carlos Gonzalez-Valle; Emanuelle Rosas-Nava; José Guzmán-Esquivel; Isaac Roberto Labra-Salgado


International Urology and Nephrology | 2012

Effect of intraprostatic epinephrine on intraoperative blood loss reduction during transurethral resection of the prostate.

A Lira-Dale; Miguel Maldonado-Avila; José Fernando Gil-García; Enrique Hans Mues-Guizar; Rubén Nerubay-Toiber; José Guzmán-Esquivel; Ivan Delgado-Enciso


International Urology and Nephrology | 2017

Treatment of reno-ureteral colic by twelfth intercostal nerve block with lidocaine versus intramuscular diclofenac

Miguel Maldonado-Avila; Marcos Del Rosario-Santiago; Je Rosas-Nava; Ha Manzanilla-García; Victor Rios-Davila; Patricia Rodriguez-Nava; Roberto Alejandro Vela-Mollinedo; Mateo Leopoldo Garduño-Arteaga


The Journal of Urology | 2012

1260 A PROSPECTIVE RANDOMIZED STUDY COMPARING THE EFFICACY OF TAMSULOSIN, ALFUZOSIN AND PLACEBO IN THE MANAGMENT OF ACUTE URINARY RETENTION SECONDARY TO BENIGN PROSTATIC HYPERPLASIA

Miguel Maldonado-Avila; José Alfredo Sierra-Ramírez; Ha Manzanilla-García; Juan Carlos Gonzalez-Valle; Emmanuel Rosas-Nava; Isaac Roberto Labra-Salgado


International Urology and Nephrology | 2018

Comparison of three analgesic drug regimens with twelfth subcostal nerve block for pain control during extracorporeal shock wave lithotripsy

Miguel Maldonado-Avila; Leopoldo Mateo Garduño-Arteaga; Roberto Alejandro Vela-Mollinedo; Jorge Jaspersen-Gastelum; Francisco Virgen-Gutierrez; Marcos Del Rosario-Santiago; Victor Rios-Davila


Revista Mexicana de Urología | 2017

Es realmente necesario evaluar el factor masculino en la era de las técnicas de reproducción asistida

Mirna Guadalupe Echavarria-Sanchez; Miguel Maldonado-Avila; Jose de Jesus Oswaldo Islas-Garcia; Melissa Maria Morales-Berrocal

Collaboration


Dive into the Miguel Maldonado-Avila's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Je Rosas-Nava

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José Guzmán-Esquivel

Mexican Social Security Institute

View shared research outputs
Top Co-Authors

Avatar

A Lira-Dale

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge